BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
World J Virol. Mar 25, 2026; 15(1): 114321
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.114321
Table 5 Risk factors for cytomegalovirus infection in liver transplantation recipients
Risk factors of CMV infection in LT patients
CMV sero-negative status
High dose maintenance immunosuppression
Use of lymphocyte depleting agents like anti-thymocyte globulin, alemtuzumab and muromonab
LT recipients more than kidney transplant recipients
Donor/recipient advanced age
Human leukocyte antigen mismatch
Immediate graft rejection
Impaired humoral immunity
Co-infection with other herpes virus


Write to the Help Desk